Bacil Pharma Ltd Approves Rights Issue and Capital Increase; Independent Directors Resign
Bacil Pharma Limited announced several significant outcomes from its Board of Directors meeting held on July 9, 2026, approving plans for capital augmentation while also confirming changes to its board composition.The Board approved a proposal to raise funds through a Rights Issue of equity shares amounting up to ₹50,00,00,000 (Rupees Fifty Crores Only). Simultaneously, the company approved an increase in its Authorized Share Capital by an additional ₹45,00,00,000 (Rupees Forty-Five Crores Only).This capital expansion involves issuing 4,50,00,000 Equity Shares of Rs. 10/- each face value. Following the approval of this increase, the company’s...